Flow cytometry showed increased CD14+CD86+ monocytes (47.50 ± 10.30% vs. 29.96 ± 12.29%, p = 0.004) (Fig. 2a) and decreased CD14+CD163+ monocytes (46.61 ± 12.98% vs. 59.94 ± 10.86%, p = 0.026) (Fig. 2b) in SLE patients. Here, CD14 is linked to systemic lupus erythematosus.